Education History

1. Bachelor of Nursing Science Srisavarindhira Thai Red Cross Institute of Nursing, 2001

E-mail

kullanan.s@ubu.ac.th Tel.061-4597932

RESEARCH EXPERIENCE

1. A randomized, blinded, positive control phase Ia trial to evaluate the safety and immunogenicity of a SARS-CoV-2 mRNA chimera vaccine (RQ3013) in healthy adults aged 18-59 years

2. A Phase III, Parallel Group, Prospective, Randomized, Doubleblind, Activecontrolled, Two-arm Study to Evaluate the Immunogenicity, Safety, and Tolerability of the SARS-CoV-2 Vaccine Candidate MVC-COV1901Compared to AZD1222 Vaccine in Adult Volunteers of 18 Years and Above